{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:04:54Z","timestamp":1781849094238,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1060407"],"award-info":[{"award-number":["1060407"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1158763 to A.L.S"],"award-info":[{"award-number":["1158763 to A.L.S"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction and Aims<\/jats:title><jats:p>Inappropriate benzodiazepine use continues to cause substantial morbidity and mortality globally. We aimed to characterise the initiation of new benzodiazepine treatment episodes in Australia and identify correlates of potentially inappropriate benzodiazepine use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Methods<\/jats:title><jats:p>We conducted a population\u2010based cohort study using dispensing claims from a 10% sample of Pharmaceutical Benefit Scheme eligible Australians (2014\u20132017). Our cohort comprised adults initiating a new benzodiazepine treatment; we defined potentially inappropriate use as \u22653 benzodiazepine dispensing over any continuous 90\u2010day period in the year following initiation. We examined characteristics associated with potentially inappropriate benzodiazepine use using multivariable logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>People initiating a new benzodiazepine treatment episode (<jats:italic>n<\/jats:italic> = 276\u2009765) were more frequently female (59.1%) and\u2009&lt;65\u2009years of age (73.6%). In the 90\u2009days prior to initiating benzodiazepine, people were commonly dispensed antidepressants (26.5%), opioid analgesics (17.6%) and antipsychotics (4.7%). In the first year after initiation, 20\u2009938 (9.5%) people experienced \u2018potentially inappropriate use\u2019. Having a greater initial quantity of benzodiazepine dispensed [odds ratio (OR), 1.10; 95% confidence interval (CI) 1.08\u20131.12 per 10 defined daily doses increase], dispensing of antipsychotics (OR 3.00, 95% CI 2.86\u20133.15) and\u2009&gt;5 unique medicines (OR 2.54, 95% CI 2.44\u20132.64; vs. \u22645 unique medicines) in the 90\u2009days prior to initiation were associated with potentially inappropriate benzodiazepine use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Approximately, 1 in 10 people who initiated benzodiazepines were using it beyond the guideline recommended period. We identified factors at the time of initiation associated with potentially inappropriate use; clinicians should consider these before prescribing benzodiazepines and initiate conversations about alternative therapy when necessary.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13086","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:39:09Z","timestamp":1589193549000},"page":"575-582","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Potentially inappropriate benzodiazepine use in Australian adults: A population\u2010based study (2014\u20132017)"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2818-6647","authenticated-orcid":false,"given":"Danni","family":"Zheng","sequence":"first","affiliation":[{"name":"Medicines Policy Research Unit, Centre for Big Data Research in Health UNSW Sydney  Sydney Australia"},{"name":"Translational Australian Clinical Toxicology Program, School of Medical Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Brett","sequence":"additional","affiliation":[{"name":"Translational Australian Clinical Toxicology Program, School of Medical Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"St Vincent's Hospital, Sydney and New South Wales Poisons Information Centre  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Daniels","sequence":"additional","affiliation":[{"name":"Medicines Policy Research Unit, Centre for Big Data Research in Health UNSW Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Buckley","sequence":"additional","affiliation":[{"name":"Translational Australian Clinical Toxicology Program, School of Medical Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie\u2010Anne","family":"Pearson","sequence":"additional","affiliation":[{"name":"Medicines Policy Research Unit, Centre for Big Data Research in Health UNSW Sydney  Sydney Australia"},{"name":"Menzies Centre for Health Policy The University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Schaffer","sequence":"additional","affiliation":[{"name":"Medicines Policy Research Unit, Centre for Big Data Research in Health UNSW Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.003"},{"key":"e_1_2_8_3_1","volume-title":"Drug induced deaths in Australia: A changing story","author":"Australian Bureau of Statistics","year":"2016"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303061"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5205"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14019"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.357"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03563.x"},{"key":"e_1_2_8_9_1","volume-title":"Psychotropics","author":"eTG complete (Australian Therapeutics Guidelines)","year":"2017"},{"key":"e_1_2_8_10_1","first-page":"2018","volume-title":"Australian Medicines Handbook","author":"Australian Medicines Handbook Pty Ltd","year":"2018"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4551"},{"key":"e_1_2_8_12_1","unstructured":"The Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice Part B: Benzodiazepines2018. Available at:https:\/\/www.racgp.org.au\/clinical-resources\/clinical-guidelines\/key-racgp-guidelines\/view-all-racgp-guidelines\/prescribing-drugs-of-dependence\/prescribing-drugs-of-dependence-part-b. (accessed 3 August 2018)."},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867417721018"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15292"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12626"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0548-0"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4821"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0056-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.2413"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182362484"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X684385"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/02813432.2017.1358436"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1616-8"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12315"},{"key":"e_1_2_8_25_1","unstructured":"Australian Bureau of Statistics.2019]. Quarterly Population Estimates. Available at:http:\/\/stat.data.abs.gov.au\/Index.aspx?DataSetCode=ERP_QUARTERLY(accessed August 2019)."},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13570"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.0544"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j760"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.1273"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.54.10.1395"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.234"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13369"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.08.005"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.2992"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1899"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.13086","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13086","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13086","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T22:00:51Z","timestamp":1693951251000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/dar.13086"],"URL":"https:\/\/doi.org\/10.1111\/dar.13086","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"2019-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}